a science-native venture firm
Specialist biotech investing.
We back early-stage biotech companies and acquire LP interests in biotech venture funds.
A Specialist Biotech Investment Firm.
Backing novel ways to understand biology and treat disease.
strategies
An investment platform grounded in scientific insight.
Our strategies span biotech company formation, early-stage venture investing and the acquisition of interests in biotech venture funds.
01 / United States
US Venture
DirectPre-Seed to Series A
Tachyon Fund I and Fund II
We back US biotech companies from pre-seed to Series A, including academic spinouts and founders with differentiated biology, technology or proprietary data.
Explore US Venture →
02 / Europe
Europe Venture
DirectEarly-stage
Tachyon Europe
We back European biotech companies at the earliest stages, connecting academic research with our US investment experience and international network.
Explore Europe Venture →
03 / UNITED STATES
Secondaries
lp fund interestSlate-stage biotech
Tachyon Entier Capital
We acquire limited partner interests in portfolios of late-stage (Phase 3) biotech companies managed by top-tier venture capital funds, primarily in the United States.
Explore secondaries →
team
Experts in risk-assessment.
Our team brings experience in scientific research, early-stage investing, company building and venture secondaries. Meet the people responsible for our strategies and the specialists who contribute to our work.
learn more about our team →Portfolio
Explore our venture portfolio.
Insights
Research & Investment Perspectives.
Read our investment perspectives, new investment announcements and portfolio company news.
contact
Start a conversation.
Discuss Tachyon’s investment strategies and request further information. Tell us about the company you are building and the science behind it. Discuss the potential sale or transfer of a biotech fund interest.